Recursion Pharmaceuticals is a Biotech company based in Salt Lake City, UT. It has raised $900M in total funding. Latest round: IPO.
Recursion Pharmaceuticals funding overview
Recursion Pharmaceuticals is a Biotech company based in Salt Lake City, UT. Recursion Pharmaceuticals has raised $900M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO. Investors on record include Data Collective, Takeda, Bayer, NIH. 4 distinct backers are named across the disclosed rounds.
Recursion Pharmaceuticals at a glance
Total raised
$900M
Latest round
IPO
Industry
Biotech
Headquarters
Salt Lake City, UT
Notable investors
Data Collective, Takeda, Bayer, NIH
Frequently asked about Recursion Pharmaceuticals funding
How much has Recursion Pharmaceuticals raised?
Recursion Pharmaceuticals has raised $900M in total disclosed funding across the rounds on record.
Who has invested in Recursion Pharmaceuticals?
Data Collective, Takeda, Bayer, NIH are named among the investors backing Recursion Pharmaceuticals.
What was the latest Recursion Pharmaceuticals funding round?
The most recent disclosed round is an IPO.
Where is Recursion Pharmaceuticals based?
Recursion Pharmaceuticals is based in Salt Lake City, UT.
What sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals is tracked under Biotech from Salt Lake City, UT, with $900M in disclosed funding.
Recursion Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Salt Lake City below to benchmark round size and investor mix.
Companies related to Recursion Pharmaceuticals (40)
